Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
MKL Diagnostics AB
AB
Dissolved
Org 5568703473
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2011 · 14 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other chemical products n.e.c.
/
MKL Diagnostics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
5M
4M
2M
1M
0M
2020: 4M
4M
2020
2021: 2M (-50% vs 2020)
2M
-50%
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
7M
1M
-5M
-11M
-17M
2020: -7M
-7M
2020
2021: -7M (0% vs 2020)
-7M
0%
2021
2022: -11M (-57% vs 2021)
-11M
-57%
2022
2023: -12M (-9% vs 2022)
-12M
-9%
2023
2024: 2M (+117% vs 2023)
2M
+117%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
399
1 819
3 689
Staff expenses
—
—
—
—
—
EBITDA
1 539
−11 955
−11 187
−7 458
−6 811
Depreciation & amort.
−14
−14
−14
−14
−10
EBIT
1 525
−11 969
−11 201
−7 472
−6 821
Net financials
—
—
—
5
13
Profit before tax
1 525
30
298
533
1 692
Tax
−316
−13
−66
−123
−296
Net profit
1 209
17
232
410
1 396
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
4 206
4 873
3 971
3 640
3 060
Equity
3 862
2 652
2 635
2 403
1 993
Long-term debt
0
0
0
0
0
Short-term debt
344
2 221
1 336
1 237
1 066
Total debt
344
2 221
1 336
1 237
1 066
Financial ratios
5-year trend
EBITDA margin
>999 %
This company
15,8 %
Market median
This company
Market median
>999% above market
2020
2024
Equity ratio
91,8 %
This company
38,2 %
Market median
This company
Market median
140% above market
2020
2024
Return on equity
31,3 %
This company
18,4 %
Market median
This company
Market median
70% above market
2020
2024
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,09×
This company
0,62×
Market median
This company
Market median
85% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2020-03-31
View
PDF
More on MKL Diagnostics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
